Pacer Advisors
VNDA icon

Pacer Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Pacer Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Buy
+1,064
New +$6.95K ﹤0.01% 2379
2023
Q1 		– Sell
-313,362
Closed -$2.32M – 2385
2022
Q4 		$2.32M Buy
313,362
+82,066
+35% +$799K 0.01% 542
2022
Q3 		$2.29M Sell
231,296
-24,478
-10% -$258K 0.02% 424
2022
Q2 		$2.79M Buy
255,774
+41,987
+20% +$435K 0.02% 420
2022
Q1 		$2.42M Buy
213,787
+107,664
+101% +$1.42M 0.02% 557
2021
Q4 		$1.67M Buy
106,123
+35,511
+50% +$619K 0.02% 902
2021
Q3 		$1.21M Buy
70,612
+13,677
+24% +$240K 0.02% 807
2021
Q2 		$1.23M Buy
56,935
+23,812
+72% +$426K 0.02% 774
2021
Q1 		$498K Buy
33,123
+21,239
+179% +$344K 0.01% 1064
2020
Q4 		$156K Buy
11,884
+1,067
+10% +$12.8K ﹤0.01% 1276
2020
Q3 		$104K Buy
10,817
+5,641
+109% +$60.3K ﹤0.01% 1244
2020
Q2 		$59K Sell
5,176
-60
-1% -$679 ﹤0.01% 857
2020
Q1 		$60K Sell
5,236
-5,460
-51% -$67.7K ﹤0.01% 535
2019
Q4 		$176K Sell
10,696
-5,429
-34% -$82.1K 0.01% 1120
2019
Q3 		$214K Buy
16,125
+6,316
+64% +$88K ﹤0.01% 1086
2019
Q2 		$138K Buy
+9,809
New +$156K ﹤0.01% 1083
2018
Q4 		– Sell
-3,823
Closed -$88K – 1031
2018
Q3 		$88K Buy
+3,823
New +$78.1K ﹤0.01% 1104
2018
Q1 		– Sell
-1,125
Closed -$17K – 1132
2017
Q4 		$17K Buy
+1,125
New +$16.7K ﹤0.01% 1110

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacer Advisors's VNDA Position: Q2 2026 in Review

Pacer Advisors opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 1,064 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #2379 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in VNDA as recently as Q4 2022.

Pacer Advisors first reported a position in VNDA in Q4 2017 and has held it in 18 quarters since. The position peaked at $2.79M in Q2 2022. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Pacer Advisors held 1,064 shares of Vanda Pharmaceuticals worth $7K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Pacer Advisors position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2379 holding.
  • Pacer Advisors first reported a position in Vanda Pharmaceuticals in Q4 2017 and has held it in 18 quarters since.
  • Pacer Advisors's Vanda Pharmaceuticals position peaked at $2.79M in Q2 2022.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.